Institute of Living/Hartford Hospital
Hartford, Connecticut 06106
We've found
3 trials
at this facility
Depressive Disorder, Major Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Obsessive-Compulsive Disorder Clinical Trial
Updated: 12/31/1969
BHV-4157 in Adult Subjects With Obsessive Compulsive Disorder
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Updated: 12/31/1969
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials